Self-reported adverse reactions among patients initiating antiretroviral therapy in Brazil
Pádua, Cristiane A. Menezes de; César, Cibele C; Bonolo, Palmira F; Acurcio, Francisco A; Guimarães, Mark Drew C.
Braz. j. infect. dis
; 11(1): 20-26, Feb. 2007. tab
Artigo em Inglês | LILACS | ID: lil-454678
Exploring concentration response in HIV pre-exposure prophylaxis to optimize clinical care and trial design.
Adverse Neuropsychiatric Events and Recreational Use of Efavirenz and Other HIV-1 Antiretroviral Drugs.
Self-reported adverse reactions among patients initiating antiretroviral therapy in Brazil.
Timing of Initiation of Antiretroviral Therapy and Risk of Preterm Birth in Studies of HIV-infected Pregnant Women: The Role of Selection Bias.
Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS.
Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
Strategies for an HIV cure: progress and challenges.
Single-Tablet Regimens for the Treatment of HIV-1 Infection.
Backbones versus core agents in initial ART regimens: one game, two players.
Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection.